Veradermics Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Veradermics Inc's ROA in the second quarter of 2026?
Veradermics Inc recorded a cumulative net loss of $-72 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -12.62%.

However, within the Healthcare sector Veradermics Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2026 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Total Assets Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-72	-59	-29	-29	-11
Return On Assets (TTM)	-12.62 %	-37.94 %	-51.46 %	-161.02 %	-
MANE's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	1,644	397	154	72	0
Seq. Total Assets Change	314.13 %	157.99 %	112.88 %	-	-
Seq. Net Income Change	-	-	-	-	-

MANE's 5 Years Annual ROA >> Back to MANE Management Effectiveness >> Compare MANE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Veradermics Inc's Assets	$ 1,644 million	MANE's Balance sheet
Veradermics Inc's Income	$ -24 million	Quarterly MANE's Income Statement
MANE's Income by Division		See MANE's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	153	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-83	0	0	0	0
Annual Return On Assets	-54.63 %	-	-	-	-

MANE's 5 Years Annual ROA >> Back to MANE Management Effectiveness >> Compare MANE ROA to its Competitors

More Return On Assets Ratios
MANE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MANE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MANE's Competitors
Subscribers only: Roa for Veradermics Inc's Suppliers
Subscribers only: Return On Assets for MANE's Customers

You may also want to know
MANE's Roi	MANE's Inventory Turnover Ratio	MANE's Growth Rates	MANE's Dividend Comparisons
	MANE's Profitability Ratios	MANE's Asset Turnover Ratio	MANE's Dividend Growth
MANE's Roe	MANE's Valuation Ratios	MANE's Financial Strength Ratios	MANE's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:43:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.